Central Nervous System Metastases
Edwin Nieblas‐Bedolla(Harvard University), Priscilla K. Brastianos(Massachusetts General Hospital), Harriet M. Kluger(Yale Cancer Center), Jeffrey Zuccato(University of Oklahoma), Gelareh Zadeh(University Health Network)
Cited by 21
Related Papers
Nivolumab plus Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2013|4.2k
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
|Journal of Clinical Oncology|2014|2.2k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Longitudinal molecular trajectories of diffuse glioma in adults
|Nature|2019|594
Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab
|Journal of Clinical Oncology|2015|443